浙江临床医学
浙江臨床醫學
절강림상의학
ZHEJIANG CLINICAL MEDICAL JOURNAL
2015年
6期
901-902,903
,共3页
胆囊肿瘤%药物疗法%三氧化二砷注射液%化疗
膽囊腫瘤%藥物療法%三氧化二砷註射液%化療
담낭종류%약물요법%삼양화이신주사액%화료
Gallbladder cancer%Drug therapy%Arsenic trioxide injection%Chemotherapy
目的:观察三氧化二砷(As2O3)注射液联合化疗治疗晚期胆囊癌的近期疗效和不良反应。方法晚期胆囊癌患者41例,随机分为观察组21例,采用顺铂(GP方案)方案化疗,化疗开始时,联合As2O3注射液10mg加入5%葡萄糖溶液500ml中,静脉滴注,1次/d,持续14d。对照组20例,采用GP方案化疗。结果>2个周期疗效评价,观察组总缓解率为52.38%,其中完全缓解(CR)1例、部分缓解(PR)10例、稳定(SD)6例和进展(PD)4例。对照组总缓解率为35.00%,其中CR 1例,PR 6例,SD 5例,PD 8例。主要不良反应为消化道反应及轻度的骨髓抑制和肝功能损害。结论 As2O3注射液联合化疗治疗晚期胆囊癌有较好疗效,不良反应少。
目的:觀察三氧化二砷(As2O3)註射液聯閤化療治療晚期膽囊癌的近期療效和不良反應。方法晚期膽囊癌患者41例,隨機分為觀察組21例,採用順鉑(GP方案)方案化療,化療開始時,聯閤As2O3註射液10mg加入5%葡萄糖溶液500ml中,靜脈滴註,1次/d,持續14d。對照組20例,採用GP方案化療。結果>2箇週期療效評價,觀察組總緩解率為52.38%,其中完全緩解(CR)1例、部分緩解(PR)10例、穩定(SD)6例和進展(PD)4例。對照組總緩解率為35.00%,其中CR 1例,PR 6例,SD 5例,PD 8例。主要不良反應為消化道反應及輕度的骨髓抑製和肝功能損害。結論 As2O3註射液聯閤化療治療晚期膽囊癌有較好療效,不良反應少。
목적:관찰삼양화이신(As2O3)주사액연합화료치료만기담낭암적근기료효화불량반응。방법만기담낭암환자41례,수궤분위관찰조21례,채용순박(GP방안)방안화료,화료개시시,연합As2O3주사액10mg가입5%포도당용액500ml중,정맥적주,1차/d,지속14d。대조조20례,채용GP방안화료。결과>2개주기료효평개,관찰조총완해솔위52.38%,기중완전완해(CR)1례、부분완해(PR)10례、은정(SD)6례화진전(PD)4례。대조조총완해솔위35.00%,기중CR 1례,PR 6례,SD 5례,PD 8례。주요불량반응위소화도반응급경도적골수억제화간공능손해。결론 As2O3주사액연합화료치료만기담낭암유교호료효,불량반응소。
Objective To evaluate the effect and toxicity of arsenic trioxide(As2O3)injection combined with chemotherapy in treating advanced gallbladder cancer.Methods Forty-one advanced gallbladder cancer patients were randomized into two groups. All received GP regimen:Gemcitabine 1000mg/m2 on days 1 and 8,and cisplatin 30mg/m2 on days 1~3.The chemotherapy was repeated every 3 weeks as one cycle.Besides,to the treatment group(21 patients),10mg As2O3 injection was adding in 500ml 5%glucose for intravenous dripping every day for 14 successive days. Results After the treatment,the objective response rate of the treatment group was 52.38%,CR 1,PR 10,SD 6,PD 4. The major side reactions were I-Ⅱ degree gastrointestinal tract reaction,mild bone marrow suppression and hepatic functional damage. The objective response rate of the compare group was 35.00%,CR 1,PR 6,SD 5,PD 8. Conclusion As2O3 injection combined with chemotherapy is effective in treating advanced gallbladder cancer with mild side reactions.